News & Events
Announcements
15 November 2009
Proacta to present at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston
Two posters will be presented:
Cellular metabolism, murine pharmacokinetics and preclinical antitumor activity of SN29966, a novel hypoxia-activated irreversible pan-HER inhibitor. Adam V. Patterson, Jagdish Jaswail, Sophie P. Syddall, Maria Abbattista, Wouter van Leeuwen, Michelle Puryer, Aaron Thompson, Annie Hsu, Sunali Mehta, Alison Pruijn, G. Leon Lu, Fernando Donate, William A. Denny, William R. Wilson, and Jeffrey B. Smaill.
Design and identification of the novel hypoxia-activated irreversible pan-HER inhibitor SN 29966. Jeff B. Smaill, Guo-Liang Lu, Wouter van Leeuwen, Maria Abbattista, Robert F. Anderson, William A. Denny, Fernando Doņate, Jagdish Jaiswal, Andrej Maroz, Michelle Puryer, Sophie P. Syddall, William R. Wilson and Adam V. Patterson.
Back to top
